相关实验视频

Updated: Jul 15, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

揭示HCV NS3/4A蛋白酶中索福斯布维尔耐药性的机制:基于结构和分子模拟的见解

Muhammad Shahab¹, Abbas Khan², Salman Ali Khan³

¹State Key Laboratories of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China.

International journal of biological macromolecules

|April 17, 2024

概括

肝炎C病毒 (HCV) 在NS3/4A蛋白酶中的药物耐药性突变降低了Sofosbuvir的疗效. 这项研究揭示了原子级耐药性机制,指导了未来针对HCV感染的抗病毒药物设计.

科学领域:

病毒学病毒学
药物发现药物发现药物发现
计算生物学计算生物学

背景情况:

肝炎C病毒 (HCV) 感染管理依赖于直接作用抗病毒药物 (DAA).
在HCVNS3和NS5B区域出现的与耐药性相关的突变降低了DAA的有效性.
索福斯布维尔是一种关键的HCVNS3/4A蛋白酶抑制剂,由于特定突变,其疗效降低.

研究的目的:

阐明HCVNS3/4A蛋白酶对Sofosbuvir的耐药性机制.
研究高水平抗性突变 (A156Y,L36P,Q41H,Q80K) 的结构和功能影响.
为改善药物开发提供关于Sofosbuvir耐药性的原子级洞察力.

主要方法:

分子动力学 (MD) 模拟.分子动力学 (MD) 模拟.
分子力学/一般化天生的表面积 (MM/GBSA) 的计算.
主要组件分析 (PCA) 和自由能源景观分析.

主要成果:

鉴定了由于特定突变而导致的HCV NS3/4A蛋白酶活性的显著变化.
蛋白质动态和影响索福斯布维尔结合的相互作用的特征变化.
提出了Sofosbuvir耐药性的详细原子级模型.

结论:

在HCVNS3/4A蛋白酶中发现的突变显著影响了Sofosbuvir的活性.
了解这些耐药机制对于设计下一代HCV疗法至关重要.
这项研究为开发针对HCV的新型抗病毒策略提供了有价值的指导.

关键词:

抗生素耐药性抗生素耐药性一个DAA就是DAA.感染HCV的感染.分子对接是分子对接.模拟模拟是为了模拟.

更多相关视频

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...